Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
9wj7FveU0wwDcFdv
